Edwards Lifesciences Corporation (BIT:1EW)

Ligand Pharmaceuticals Revenue

Edwards Lifesciences had revenue of $1.53B USD in the quarter ending June 30, 2025, with 11.89% growth. This brings the company's revenue in the last twelve months to $5.69B, up 9.14% year-over-year. In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth.

• Revenue (ttm): $5.69B
• Revenue Growth: +9.14%
• P/S Ratio: 8.04
• Revenue / Employee: $359.82K
• Employees: 15,800
• Market Cap: 38.93B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.44B	429.50M	8.57%
Dec 31, 2023	5.01B	546.00M	12.23%
Dec 31, 2022	4.46B	-768.50M	-14.69%
Dec 31, 2021	5.23B	846.20M	19.29%
Dec 31, 2020	4.39B	38.30M	0.88%